Jeffrey J. Larson-Keller

1.8k total citations
15 papers, 1.4k citations indexed

About

Jeffrey J. Larson-Keller is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jeffrey J. Larson-Keller has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Jeffrey J. Larson-Keller's work include Prostate Cancer Diagnosis and Treatment (4 papers), Urologic and reproductive health conditions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Jeffrey J. Larson-Keller is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (4 papers), Urologic and reproductive health conditions (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Jeffrey J. Larson-Keller collaborates with scholars based in United States, United Kingdom and Vietnam. Jeffrey J. Larson-Keller's co-authors include Horst Zincke, Ruud A. F. Krom, Erik J. Bergstralh, Duane M. Ilstrup, Joseph E. Oesterling, Michael M. Lieber, Carlos V. Payá, Daniel Portela, Robin Patel and Russell H. Wiesner and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and Hepatology.

In The Last Decade

Jeffrey J. Larson-Keller

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey J. Larson-Keller United States 14 555 524 291 210 202 15 1.4k
Rainer P. Woitas Germany 26 434 0.8× 264 0.5× 397 1.4× 220 1.0× 163 0.8× 78 1.9k
M. Patricia George United States 23 538 1.0× 925 1.8× 216 0.7× 194 0.9× 53 0.3× 56 1.6k
Asha Moudgil United States 23 294 0.5× 279 0.5× 317 1.1× 58 0.3× 156 0.8× 111 2.0k
Jean-Michel Rebibou France 24 275 0.5× 152 0.3× 474 1.6× 51 0.2× 135 0.7× 66 1.6k
Renaud Snanoudj France 28 413 0.7× 318 0.6× 637 2.2× 70 0.3× 242 1.2× 84 2.4k
Steven Zacks United States 21 853 1.5× 598 1.1× 845 2.9× 137 0.7× 77 0.4× 31 1.9k
Robert Schilz United States 17 539 1.0× 826 1.6× 304 1.0× 385 1.8× 37 0.2× 41 1.7k
Jessica Rademacher Germany 22 465 0.8× 533 1.0× 291 1.0× 86 0.4× 41 0.2× 80 1.8k
Geoffrey K. Dube United States 20 144 0.3× 289 0.6× 593 2.0× 95 0.5× 66 0.3× 43 1.5k
M. Zanazzi Italy 18 120 0.2× 199 0.4× 214 0.7× 117 0.6× 96 0.5× 69 911

Countries citing papers authored by Jeffrey J. Larson-Keller

Since Specialization
Citations

This map shows the geographic impact of Jeffrey J. Larson-Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Larson-Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Larson-Keller more than expected).

Fields of papers citing papers by Jeffrey J. Larson-Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey J. Larson-Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Larson-Keller. The network helps show where Jeffrey J. Larson-Keller may publish in the future.

Co-authorship network of co-authors of Jeffrey J. Larson-Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Larson-Keller. A scholar is included among the top collaborators of Jeffrey J. Larson-Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Larson-Keller. Jeffrey J. Larson-Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Patel, Robin, Daniel Portela, Andrew D. Badley, et al.. (1996). RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1. Transplantation. 62(7). 926–934. 147 indexed citations
2.
Patel, Robin, Andrew D. Badley, Jeffrey J. Larson-Keller, et al.. (1996). RELEVANCE AND RISK FACTORS OF ENTEROCOCCAL BACTEREMIA FOLLOWING LIVER TRANSPLANTATION1. Transplantation. 61(8). 1192–1197. 39 indexed citations
3.
Portela, Daniel, Robin Patel, Jeffrey J. Larson-Keller, et al.. (1995). OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver Transplantation. The Journal of Infectious Diseases. 171(4). 1014–1018. 111 indexed citations
4.
Heras, Magda, James H. Chesebro, Valentı́n Fuster, et al.. (1995). High risk of thromboemboli early after bioprosthetic cardiac valve replacement. Journal of the American College of Cardiology. 25(5). 1111–1119. 214 indexed citations
5.
Panser, Laurel A., Christopher G. Chute, Harry A. Guess, et al.. (1994). The Natural History of Prostatism: The Effects of Non-Response Bias. International Journal of Epidemiology. 23(6). 1198–1205. 80 indexed citations
6.
Alcaraz, Antonio, Satoru Takahashi, James A. Brown, et al.. (1994). Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer.. PubMed. 54(15). 3998–4002. 112 indexed citations
7.
Cheng, W. S., Mark Frydenberg, Erik J. Bergstralh, Jeffrey J. Larson-Keller, & Horst Zincke. (1993). Radical prostatectomy for pathologic stage C prostate cancer: Influence of pathologic variables and adjuvant treatment on disease outcome. Urology. 42(3). 283–291. 82 indexed citations
8.
Payá, Carlos V., Russell H. Wiesner, Paul E. Hermans, et al.. (1993). Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. Journal of Hepatology. 18(2). 185–195. 130 indexed citations
9.
Kleer, Eduardo, Jeffrey J. Larson-Keller, Horst Zincke, & Joseph E. Oesterling. (1993). Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade. Urology. 41(3). 207–216. 108 indexed citations
10.
Plevak, David J., Steven R. Rettke, J. Ludwig, et al.. (1993). Predictors of primary nonfunction: is donor liver fat content important?. PubMed. 25(2). 1974–1974.
11.
Payá, Carlos V., Russell H. Wiesner, Paul E. Hermans, et al.. (1992). Lack of Association Between Cytomegalovirus Infection, Hla Matching and the Vanishing Bile Duct Syndrome After Liver Transplantation. Hepatology. 16(1). 66–70. 48 indexed citations
12.
Zincke, Horst, Erik J. Bergstralh, Jeffrey J. Larson-Keller, et al.. (1992). Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Cancer. 70(S1). 311–323. 107 indexed citations
13.
Myers, Robert P., Jeffrey J. Larson-Keller, Erik J. Bergstralh, et al.. (1992). Hormonal Treatment at Time of Radical Retropubic Prostatectomy for Stage D1 Prostate Cancer: Results of Long-Term Followup. The Journal of Urology. 147(3 Part 2). 910–915. 54 indexed citations
14.
Cockerill, Franklin R., John P. Anhalt, Herbert W. Marsh, et al.. (1992). Prevention of Infection in Critically Ill Patients by Selective Decontamination of the Digestive Tract. Annals of Internal Medicine. 117(7). 545–553. 95 indexed citations
15.
Taswell, Howard F., Mark E. Brecher, Jorge Rakela, et al.. (1989). Intraoperative Blood Loss and Patient and Graft Survival in Orthotopic Liver Transplantation: Their Relationship to Clinical and Laboratory Data. Mayo Clinic Proceedings. 64(3). 346–355. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer P. Woitas Breakdown of academic impact, for papers by M. Patricia George Breakdown of academic impact, for papers by Asha Moudgil Breakdown of academic impact, for papers by Jean-Michel Rebibou Breakdown of academic impact, for papers by Renaud Snanoudj Breakdown of academic impact, for papers by Steven Zacks Breakdown of academic impact, for papers by Robert Schilz Breakdown of academic impact, for papers by Jessica Rademacher Breakdown of academic impact, for papers by Geoffrey K. Dube Breakdown of academic impact, for papers by M. Zanazzi
Rankless by CCL
2026